Biocon has informed that it enclosed the press release titled ‘Biocon Limited launches its Glucagon-like Peptide-1 (GLP - 1), Liraglutide, in the Netherlands’. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.